Testing effectiveness (Phase 2)UnknownNCT03612232What this trial is testingCabozantinib in Advanced Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Wuerzburg University Hospital 37
Early research (Phase 1)Looking for participantsNCT07189403What this trial is testingDS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerWho this might be right forAdvanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer Daiichi Sankyo 40
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Testing effectiveness (Phase 2)Ended earlyNCT00002921What this trial is testingS9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by SurgeryWho this might be right forAdrenocortical Carcinoma SWOG Cancer Research Network 13
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01514526What this trial is testingClinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Spanish Oncology Genito-Urinary Group 17
Very early researchStudy completedNCT00436410What this trial is testingTumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerWho this might be right forAdrenocortical CarcinomaBreast CancerColorectal Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00848016What this trial is testingGossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT06006013What this trial is testingCabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical CancerWho this might be right forLocally Advanced Adrenal Cortex CarcinomaAdrenal Cortical CarcinomaStage III Adrenal Cortex Carcinoma+2 more Emory University 21
Large-scale testing (Phase 3)Study completedNCT00924989What this trial is testingOSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Study completedNCT03370718What this trial is testingCabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaWho this might be right forMetastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more M.D. Anderson Cancer Center 18
Early research (Phase 1)Ended earlyNCT03746431What this trial is testing[225Ac]-FPI-1434 InjectionWho this might be right forAdvanced Solid TumoursEndometrial CancerCervical Cancer+7 more Fusion Pharmaceuticals Inc. 78
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT04187404What this trial is testingA Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/ParagangliomaWho this might be right forAdrenocortical CarcinomaPheochromocytomaParaganglioma Enterome 70